S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|BrainStorm Cell Therapeutics to Host Conference Call to Discuss Final Results of Phase 2a Trial of NurOwn™ in ALS on January 5, 2015|
|BrainStorm Cell Therapeutics to Report Third Quarter 2014 Financial Results on Thursday, November 13|
|BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office|
|BrainStorm CEO to Present at Two Upcoming Investor Conferences|
|BrainStorm Announces Final Analysis of Phase 2a ALS Study Showing Nearly All Subjects Experienced Clinical Benefit from NurOwn™|
|BrainStorm Enters Into Warrant Exercise Agreement for Approximately $13 Million in Proceeds|
|BrainStorm Announces Receipt of Approximately $3.1 Million from Warrant Exercises|
|BrainStorm Announces Financial Results for the Third Quarter of 2014 and Provides Corporate Update|
|Synta Strengthens Management Team with Two Executive Appointments|
Click above to view more mutual fund data and stats for bcli - Brainstorm Cell Therapeutics Inc.